S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
ETR:AFX

Carl Zeiss Meditec (AFX) Stock Price, News & Analysis

€119.40
+0.60 (+0.51%)
(As of 03/27/2024 ET)
Today's Range
€118.50
€120.00
50-Day Range
€98.00
€121.95
52-Week Range
€72.60
€136.40
Volume
60,063 shs
Average Volume
94,405 shs
Market Capitalization
$10.68 billion
P/E Ratio
38.52
Dividend Yield
0.92%
Price Target
€175.00

Carl Zeiss Meditec MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
46.6% Upside
€175.00 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.87mentions of Carl Zeiss Meditec in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.11 out of 5 stars

AFX stock logo

About Carl Zeiss Meditec Stock (ETR:AFX)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

AFX Stock Price History

AFX Stock News Headlines

Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG (AFX.DE)
Carl Zeiss Meditec AG (AFX.SW)
Carl Zeiss Meditec AG ADR (CZMWY)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Carl Zeiss Meditec AG AFX
AFX.DE - Carl Zeiss Meditec AG
When Should You Buy Carl Zeiss Meditec AG (ETR:AFX)?
See More Headlines
Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
4,823
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
€175.00
High Stock Price Target
€175.00
Low Stock Price Target
€175.00
Potential Upside/Downside
+46.6%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$276.80 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.09 billion
Cash Flow
€0.09 per share
Book Value
€24.14 per share

Miscellaneous

Free Float
N/A
Market Cap
$10.68 billion
Optionable
Not Optionable
Beta
0.92
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Dr. Markus Weber
    CEO & Chairman of Management Board
  • Mr. Justus Felix Wehmer (Age 59)
    CFO & Member of the Management Board
    Comp: $609.4k
  • Dr. Christian Munster (Age 53)
    Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board
  • Stefanie Spanagel
    Chief Operating Officer
  • Mr. Sebastian Frericks
    Director of Investor Relations
  • Eva-Maria Heine
    Chief Human Resources Officer
  • Mr. Steven C. Schallhorn M.D.
    Chief Medical Officer for Global Ophthalmic Devices
  • Mr. Andrew Chang
    Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.
  • Dr. Euan S. Thomson Ph.D. (Age 61)
    President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit
  • Mr. Magnus Reibenspiess
    Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology

AFX Stock Analysis - Frequently Asked Questions

What is Carl Zeiss Meditec's stock price target for 2024?

0 brokers have issued 12 month target prices for Carl Zeiss Meditec's stock. Their AFX share price targets range from €175.00 to €175.00. On average, they expect the company's stock price to reach €175.00 in the next twelve months. This suggests a possible upside of 46.6% from the stock's current price.
View analysts price targets for AFX
or view top-rated stocks among Wall Street analysts.

How have AFX shares performed in 2024?

Carl Zeiss Meditec's stock was trading at €98.84 at the beginning of the year. Since then, AFX shares have increased by 20.8% and is now trading at €119.40.
View the best growth stocks for 2024 here
.

Is Carl Zeiss Meditec a good dividend stock?

Carl Zeiss Meditec (ETR:AFX) pays an annual dividend of €1.10 per share and currently has a dividend yield of 0.94%. The dividend payout ratio is 35.48%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Carl Zeiss Meditec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Covestro (1COV), AbbVie (ABBV), Allianz (ALV), Daimler (DAI), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM) and SAP (SAP).

This page (ETR:AFX) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners